Showing 163 articles tagged

Behind the headlines: Tall men at increased risk of dying from prostate cancer

13 Jul 2017

New research shows that taller men have an increased risk of dying from prostate cancer, but how worried should men really be? We take a closer look at the findings...

Men dangerously unaware of family link to prostate cancer new research finds

13 Jun 2017

Prostate Cancer UK urges people to have vital talks with their relatives and GP about the most common cancer in men, after our new study reveals half of all UK men don't know about their increased risk of the disease if other family members have had it.

STAMPEDE and Latitude trial results: how will they benefit men?

6 Jun 2017

BLOG: Our CEO gives her thoughts on new research could mean for treating prostate cancer and how Prostate Cancer UK is working to make the most of it.

New STAMPEDE trial results show earlier abiraterone could improve survival of men with advanced prostate cancer

3 Jun 2017

Announced by researchers at a cancer conference in Chicago, the new findings show earlier and combined use of existing treatments can have a significant impact on advanced disease, but questions remain about its suitability for all men.

New blood test could help ‘personalise’ treatment for advanced prostate cancer and save NHS cash

4 May 2017

New research funded by Prostate Cancer UK has discovered a blood test that can predict which men's cancer won't respond to certain hormone therapy, so they can pick the treatment that works for them while saving the NHS potentially huge sums on otherwise wasted drugs.

Progress and promise in a fast-moving year since the launch of our life-saving strategy

3 Mar 2017

BLOG: It's been 12 months since we launched our ambitious plan to halve prostate cancer deaths in a decade, and we’ve already taken some huge steps towards our goal. Our chief executive, Angela Culhane, reflects on the progress we’ve made and the exciting work still to come.

Researchers discover new genetic signature for aggressive prostate cancer

1 Mar 2017

We welcome today's reports of a new test by scientists at the University of East Anglia to determine whether a prostate cancer is aggressive or not, but the tell-tale pattern of 45 specific genes hasn't yet been proven to work for all men.

Only a third of men currently benefit from 'biggest leap forward in diagnosis for decades'

20 Jan 2017

After today's confirmation that mpMRI scans before a biopsy can radically improve the accuracy of prostate cancer diagnosis, figures reveal that just 32% of eligible men currently have access to the procedure because of a shortage of scanners and qualified staff to use them in the NHS.

How playing the long game and your donations led to mpMRI breakthrough

20 Jan 2017

BLOG: Today's announcement about mpMRI scans before a biopsy is a game-changer for prostate cancer diagnosis. But without Prostate Cancer UK's funding of a pilot project in 2010 thanks to your donations, this ground-breaking research would never have happened, says Dr Ian Le Guillou.

What a difference a year in research makes

29 Dec 2016

BLOG: We're only 12 months into our ten-year strategy to tame prostate cancer, but that doesn't mean we haven't already made exciting progress. Our resident expert, Dr Ian Le Guillou, gives us his top ten biggest research breakthroughs (in no particular order) from 2016.